In addition, BTK inhibition with ibrutinib demonstrated a reduction in mast cell and IgE-dependent basophil reactivity in allergic patients with chronic lymphocytic leukemia and in patients with IgE-mediated allergy to peanut and/or tree nuts31,32. This evidence concerns the gene IGHE and Allergy.